More than a month has passed since the Yoon Suk-yeol administration launched the “Covid-19 Special Response Team” under the slogan of “scientific quarantine.”However, the team has neither appointed members nor held a single meeting.Rep. Kim Won-i of the opposition Democratic Party of Korea (DPK) rem
A research team at St. Mary's Hospital has discovered a biomarker that can predict the severity and recovery of dysphagia, or swalling difficulties, after a stroke.Dysphagia is a major cause of bacterial aspiration pneumonia as well as malnutrition and dehydration, affecting the overall recovery of
The U.S. Food and Drug Administration recommended Golden Biotechnology Corp., a Taiwanese biopharmaceutical company, to conduct an additional clinical trial of antroquinonol, a Covid-19 treatment candidate, BNC Korea said.In August 2020, Golden Biotech and BNC Korea signed an agreement for the latte
U.S. President Joe Biden on Monday signed an executive order implementing a new initiative aiming to boost biomanufacturing in pharmaceuticals.The initiative aims to help expand U.S. biomanufacturing capabilities and reduce reliance on China.According to people familiar with the matter, the order la
In recent years, the South Korean media have been churning out reports of teens overdosing on Fentanyl, a powerful narcotic analgesic similar to morphine but 50 to 100 times more potent.To prevent the abuse or misuse of the drug, Rep. Kang Sun-woo of the Democratic Party and 10 other lawmakers on Th
The Ministry of Food and Drug Safety imposed a three-month manufacturing suspension on two nutritional injection products of Samsung Pharm, GC Wellbeing Amino Inj. And GC WellBbing Neuramin Inc., last Thursday.The reason for the disposition is the “violation of the regulations on management responsi
PARIS – A Korean expert has given a positive evaluation to the phase 3 clinical trial results of VEGFR2 Tigit Tyrosine Kinase Inhibitor (TKI), “rivoceranib,” which proved effective in the first-line treatment of liver cancer combined with the anti-PD-1 immuno-cancer drug, "camrelizumab."Rivoceranib
Dx&Vx said it succeeded in raising 17.8 billion won ($12.9 million) by issuing convertible bonds (CB).According to the company, it will use the new fund for operating use and acquiring shares of other corporations. DA 1st Company Limited, a special purpose company, will acquire all CBs.The maturity
It has become almost certain that the government would cancel the licenses of all brain function-improving drugs using acetyl-L-carnitine as the main ingredient.Faced with a crisis of losing the annual 50 billion won (36.2 million) prescription market, domestic drugmakers called for the Ministry of
Mathematicians predicted that the number of new confirmed Covid-19 cases per day will drop to 50,000 in two weeks as the pandemic resurgence has turned into a declining phase.According to a report from the Covid-19 mathematical modeling task force, an Ulsan National Institute of Science and Technolo
A year has passed since Organon & Co. spun off from MSD, vowing to be a company specializing in the field of female healthcare.Over the past year, Organon has made positive efforts to promote female health. For instance, it acquired companies producing postpartum solutions to treat postpartum hyster
Global Bio Conference (GBC) 2022 ended its three-day run on Wednesday.According to the conference organizers, the GBC, hosted by the Ministry of Food and Drug Safety (MFDS), aims to set the stage for active communication aiming to lead a balanced international regulatory environment.The conference p
Korea recently scrapped requiring a Covid-19 test for inbound travelers before entry to the nation but kept the mandatory PCR test within 24 hours after arrival in Korea.However, the government is poorly monitoring mandatory PCR tests among entrants, a lawmaker said Thursday.Rep. In Jae-keun of the
A research team at Ajou University School of Medicine said a decrease in mitochondrial matrix caseinolytic protease P (ClpP) plays an important role in the pathogenesis of nonalcoholic steatohepatitis (NASH) induced by a high-fat and high-fructose diet.ClpP regulates the protein balance in mitochond
Yuyu Pharmaceutical said it launched Senuvela, a treatment for hyperphosphatemia containing Sevelamer.Senuvela can control serum phosphorus in patients with chronic kidney disease (CKD) who do not have sufficient phosphorus excretion through diet and dialysis alone.With the launch of Senuvela, Yuyu
Patients with amyloid-negative amnestic mild cognitive impairment (MCI) may be at risk of progressing to dementia even if they had subthreshold levels of amyloid deposition, a Korean study showed.The research team, led by Professor Kim Hyung-ji at the Department of Neurology of Euijeongbu Eulji Medi
Hanmi Pharm and Seoul National University (SNU) have decided to collaborate to create a hub to foster global bio-industry talents. Hanmi said the company and SNU signed a memorandum of understanding to cooperate on building a global hub to cultivate a bio workforce as part of the World Health Organi
Daewoong Pharmaceutical has won the approval for a phase 2 investigational new drug (IND) clinical trial of DWN12088, its treatment candidate for idiopathic pulmonary fibrosis (IPF), in Korea following the nod in the U.S.The Ministry of Food and Drug Safety gave the go-ahead to Daewoong’s treatment
The government will operate a total of 6,000 one-stop medical institutions during the Chuseok holiday and at least 700 one-stop medical institutions on Chuseok Day on Saturday this week, Prime Minister Han Duck-soo said during a Covid-19 response meeting on Wednesday."After we announced quarantine a
Despite the sluggish initial public offering (IPO) market continuing throughout the year, four Korean biotech companies are preparing to go public in September. The four companies are SunBio, RP Bio, Plasmapp, and Shaperon.Most biopharmaceutical companies that went public in the first half suffered